Clinical Trial: A Single-Arm, Prospective, Phase II Study on the Safety and Efficacy of Consolidative Surgery after Disease Control with Enfortumab Vedotin and Pembrolizumab in Stage IV Upper Urinary Tract Urothelial Carcinoma (Japan)

Tokyo, Oct. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063281) titled 'A study of the safety and effectiveness of surgery after enfortumab vedotin plus pembrolizumab for stage IV upper urinary tract cancer' on Oct. 19.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - another

Condition: Condition - Stage IV upper urinary tract urothelial carcinoma (renal pelvic or ureteral cancer) Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - The primary objective of this study is to prospectively evaluate the ...